Beam Therapeutics Inc. (BEAM) vs Disc Medicine, Inc. (IRON)

Beam Therapeutics Inc. and Disc Medicine, Inc. are both Biotechnology companies. Beam Therapeutics Inc. and Disc Medicine, Inc. are of similar size ($2.6B and $2.6B). Disc Medicine, Inc. has the higher net margin (0.00% vs −55.5%) and the higher return on invested capital (0.00% vs −1,599.3%). Across the 14 metrics below, Disc Medicine, Inc. leads on 8 and Beam Therapeutics Inc. on 6.

Valuation

Metric BEAM IRON Biotechnology median
P/E n/m n/m 7.88
P/S 16.23 n/m 11.47
P/B 2.37 3.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 9.48 n/m 10.73
Earnings yield (3.38%) (10.05%) (28.84%)
Free cash flow yield (14.72%) (7.84%) (23.03%)

Profitability

Metric BEAM IRON Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (242.27%) 0.00% 0.00%
Net margin (55.45%) 0.00% 0.00%
Free cash flow margin (238.90%) 0.00% 0.00%
Return on equity (8.18%) (39.08%) (57.72%)
Return on assets (6.23%) (35.12%) (49.22%)
Return on invested capital (1,599.30%) 0.00% 0.00%

Growth

Metric BEAM IRON Biotechnology median
Revenue growth (TTM) 158.88% — 5.64%
EPS growth (last fiscal year) 82.31% (51.77%) —
Revenue growth, 5-year CAGR 466.27% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BEAM IRON Biotechnology median
Debt to equity 0.09 0.09 0.00
Current ratio 14.57 24.14 4.73
Net debt to EBITDA 3.30 3.12 0.96

Dividend

Metric BEAM IRON Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BEAM IRON Biotechnology median
Market cap 2.55b 2.55b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack